Who owns Protagonist Therapeutics, Inc (PTGX)? Elite investor 13F holders
3 tracked elite investors reported holding Protagonist Therapeutics, Inc as of 2026-06-30, including Polen Capital Management, Gotham Asset Management, Bridgewater Associates. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Rubric Capital | PROTAGONIST THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| Duquesne Family Office | PROTAGONIST THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| Polen Capital Management | PROTAGONIST THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-04 00:00:00 | 2776560.00 USD | 22651.000000 | Shares | reduce | Original filing |
| Gotham Asset Management | PROTAGONIST THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 2287711.00 USD | 18663.000000 | Shares | reduce | Original filing |
| Bridgewater Associates | PROTAGONIST THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1136194.00 USD | 9269.000000 | Shares | add | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.